Sangamo Therapeutics, Inc. (0R1D.L) LSE

0.50

+0.0378(+8.26%)

Updated at November 10 07:14PM

Currency In USD

Valuation

Market Cap205.73M
Enterprise Value194.38M
P/E Ratio-2.09
PEG Ratio-0.08
Price/Sales Ratio1.9
Price/Book Ratio6.74
Enterprise/Revenue1.72
Enterprise/EBITDA-2.47

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.77
Operating Margin-0.77

Management Effectiveness

Return On Assets-0.65
Return On Equity-2.93

Income Statement

Revenue57.8M
Revenue/Share0.32
Gross Profit57.8M
EBITDA-89.09M
Net Income-97.94M
Diluted EPS-0.49

Balance Sheet

Total Cash30.53M
Total Cash/Share0.15
Total Debt25.42M
Total Debt/Equity1.2
Current Ratio1.05
Book Value Per Share0.08

Price History

52-Week Change-82.55
52-Week High2.11
52-Week Low0.29
Moving Average 50 Days0.72
Moving Average 200 Days0.81

Statistics

Average Volume47,193
Shares Outstanding301.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A